{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:48:43Z","timestamp":1789145323983,"version":"build-2803163510"},"reference-count":40,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,1,31]]},"abstract":"<jats:p>Background: The metabotropic glutamate receptor 5 (mGluR5) is widely expressed in postsynaptic neurons and plays a vital role in the synaptic plasticity of the central nervous system. mGluR5 is a coreceptor for amyloid-\u03b2 (A\u03b2) oligomer, and downregulation or pharmacological blockade of mGluR5 presents the therapeutic potential of Alzheimer\u2019s disease (AD). However, the abnormality of mGluR5 in the pathogenesis of AD and its mechanism of pathology is not clear. Objective: In this study, we would like to investigate the expression of mGluR5 in the process of AD and explore the effects and the underlying mechanisms of antagonizing mGluR5 on cognitive function, synaptic structure, and inflammation in 5xFAD mice. Methods: mGluR5 expression and interactions with PrPc in 5XFAD mice were detected using western blot and co-immunoprecipitation. The selective mGluR5 antagonist MPEP was infused into 4-month-old 5XFAD mice for 60 consecutive days. Then, cognitive function, AD-like pathology and synaptic structure were measured. Further observations were made in mGluR5 knockdown 5XFAD mice. Results: mGluR5 expression was increased with A\u03b2 levels at 6 months in 5XFAD mice. mGluR5 antagonist rescued cognitive disorders, promoted synaptic recovery, and alleviated both the A\u03b2 plaque load and abnormal hyperphosphorylation in 6-month-old 5XFAD mice. Meanwhile, the results were validated in mGluR5 knockdown mice. Blockade of mGluR5 efficiently alleviates AD-like pathologies by inhibiting the PI3K\/AKT\/mTOR pathway and activates autophagy in 5XFAD mice. Furthermore, antagonism of mGluR5 attenuated neuroinflammation by inactivating the IKK\/NF-\u03baB pathway. Conclusion: These findings suggest that mGluR5 may be an effective drug target for AD treatment, and inhibition of the mGluR5\/PI3K-AKT pathway alleviates AD-like pathology by activating autophagy and anti-neuroinflammation in 5XFAD mice.<\/jats:p>","DOI":"10.3233\/jad-221058","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:56:40Z","timestamp":1671541000000},"page":"1197-1214","source":"Crossref","is-referenced-by-count":20,"title":["Inhibition of mGluR5\/PI3K-AKT Pathway Alleviates Alzheimer\u2019s Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice"],"prefix":"10.1177","volume":"91","author":[{"given":"Yuzhao","family":"Chen","sequence":"first","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Wei","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijian","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guangzhou Municipaland Guangdong Provincial Key Laboratory of Molecular Target &Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Key Laboratory of State Administration of Traditional Chinese Medicine of China, Department of Pathophysiology, School of Medicine, Institute of Brain Research, Jinan University, Guangzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221058_ref1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221058_ref2","doi-asserted-by":"crossref","unstructured":"(2021) 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 17, 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"10.3233\/JAD-221058_ref3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of amyloid beta and tau in Alzheimer\u2019s disease: From mechanisms to therapy","volume":"34","author":"Xin","year":"2018","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-221058_ref4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221058_ref5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-221058_ref6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0028-3908(95)00085-K","article-title":"Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5","volume":"34","author":"Daggett","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-221058_ref7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-221058_ref8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.3233\/JAD-221058_ref9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","article-title":"Abeta secretion and plaque formation depend on autophagy","volume":"5","author":"Nilsson","year":"2013","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-221058_ref10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer\u2019s disease mouse models","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-221058_ref11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-221058_ref12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-221058_ref13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-221058_ref14","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/brain\/awy117","article-title":"Tau reduction in the presence of amyloid-beta prevents tau pathology and neuronal death in vivo","volume":"141","author":"DeVos","year":"2018","journal-title":"Brain"},{"key":"10.3233\/JAD-221058_ref15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/glia.20306","article-title":"Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration","volume":"53","author":"Craft","year":"2006","journal-title":"Glia"},{"key":"10.3233\/JAD-221058_ref16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-221058_ref17","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: Players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.3233\/JAD-221058_ref18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neurobiolaging.2019.08.006","article-title":"Age dependency of mGluR5 availability in 5xFAD mice measured by PET","volume":"84","author":"Lee","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221058_ref19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1096\/fj.10-161653","article-title":"Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminili \u03b31 chain","volume":"25","author":"Heraldo","year":"2010","journal-title":"FASEB J"},{"key":"10.3233\/JAD-221058_ref20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cell.2011.09.036","article-title":"Arc\/Arg3.1 regulates an endosomal pathway essential for activity-dependent beta-amyloid generation","volume":"147","author":"Wu","year":"2011","journal-title":"Cell"},{"key":"10.3233\/JAD-221058_ref21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2202-11-130","article-title":"Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer\u2019s disease model mouse","volume":"11","author":"Chung","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-221058_ref22","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein","volume":"30","author":"Gimbel","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-221058_ref23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-221058_ref24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitativemorphometric analysis of the neuronal and synaptic content of thefrontal and temporal cortex in patients with Alzheimer\u2019s disease","volume":"78","author":"Davies","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-221058_ref25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-221058_ref26","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-221058_ref27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-221058_ref28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-221058_ref29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13195-020-00666-7","article-title":"Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice","volume":"12","author":"Wei","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-221058_ref30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-221058_ref31","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: Effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-221058_ref32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","article-title":"Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Manczak","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-221058_ref33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: A pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-221058_ref34","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-221058_ref35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12976-019-0113-5","article-title":"Autophagy and apoptosis are regulated by stress on Bcl2 by AMBRA1 in the endoplasmic reticulum and mitochondria","volume":"16","author":"Yang","year":"2019","journal-title":"Theor Biol Med Model"},{"key":"10.3233\/JAD-221058_ref36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20026","article-title":"Glial modulation of synaptic transmission in culture","volume":"47","author":"Araque","year":"2004","journal-title":"Glia"},{"key":"10.3233\/JAD-221058_ref37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2006.04.021","article-title":"Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy","volume":"1095","author":"Emirandetti","year":"2006","journal-title":"Brain Res"},{"key":"10.3233\/JAD-221058_ref38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/faat.1994.1029","article-title":"Developmental toxicity and structure-activity relationships of aliphatic acids, including dose-response assessment of valproic acid in mice and rats","volume":"22","author":"Narotsky","year":"1994","journal-title":"Fundam Appl Toxicol"},{"key":"10.3233\/JAD-221058_ref39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-9-52","article-title":"Involvement of metabotropic glutamate receptor 5, AKT\/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes","volume":"9","author":"Shah","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-221058_ref40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","article-title":"Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau","volume":"267","author":"Greenberg","year":"1992","journal-title":"J Biol Chem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:04Z","timestamp":1777370824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":40,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-221058","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}